IL6 and melanoma: Moreover, upregulation of expression of IL-12, an interleukin that has been shown to elicit significant anti-tumor activity in mice and humans [76,77,78], and IL-6, which acts as a growth inhibitor in early-stage melanoma [79,80], has also been observed in PBMCs co-cultured with depigmented SKMel-188.